Sort
78,016 grants matching “breast cancer”
Sulfur(VI) Fluoride Exchange (SuFEx): new developments and biological applications
$443,750K Barry Sharpless · Scripps Research Institute, The · R01 · FY2020 · GM
Sulfur(VI) Fluoride Exchange (SuFEx): new developments and biological applications
$443,750K Barry Sharpless · Scripps Research Institute, The · R01 · FY2022 · GM
Sulfur(VI) Fluoride Exchange (SuFEx): new developments and biological applications
$443,750K Barry Sharpless · Scripps Research Institute, The · R01 · FY2023 · GM
Sulfur(VI) Fluoride Exchange (SuFEx): new developments and biological applications
$443,750K Barry Sharpless · Scripps Research Institute, The · R01 · FY2021 · GM
Human Breast Cancer Stem Cell Surrogates
$443,749Wendy A Woodward · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Patient Navigation for Cervical Cancer in Appalachia
$443,742Mark B. Dignan · University Of Kentucky · R01 · FY2009 · CA
KanSurvive: Testing a model for improving cancer survivorship care in rural practice
$443,740Jennifer Rose Klemp · University Of Kansas Medical Center · R01 · FY2022 · CA
A New Histone H3 Modification Regulates Epigenetic Programming and Gene Expression in Breast Cancer
$443,721Qing Zhang · Ut Southwestern Medical Center · R01 · FY2023 · CA
MicroRNA profiles of TN breast cancer to define subgroups and targets for therapy
$443,720Kay Huebner · Ohio State University · U01 · FY2012 · CA
NESTED NANOTHERAPEUTICS FOR DRUG SYNERGY ENHANCEMENT IN BREAST CANCER THERAPY
$443,674The Methodist Hospital Research Institute · · FY2011 · Department of Defense
Proteomics Biomarkers Development Laboratory
$443,657Samir M Hanash · Fred Hutchinson Cancer Research Center · U01 · FY2009 · CA
Targeting Chemotherapy-induced Breast Cancer Stemness
$443,640Shizhen Emily Wang · University Of California, San Diego · R01 · FY2021 · CA
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers
$443,629Paul Joseph Goodfellow · Ohio State University · R01 · FY2022 · CA
Defining BRCA replication dysfunction in therapy response
$443,626Sharon B Cantor · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · CA
Cancer in adults following in utero and early life exposure to arsenic
$443,622Craig M Steinmaus · University Of California Berkeley · R01 · FY2016 · ES
Novel L-threo-sphinganines for ceramides-based cancer therapy
$443,579Barry J Maurer · Texas Tech University Health Scis Center · R15 · FY2012 · CA
Immobilized Drug Transporters
$443,566Irving William Wainer · National Institute On Aging · ZIA · FY2011 · AG
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
$443,556Xinna Zhang · Indiana University Indianapolis · R01 · FY2024 · CA
IMRT in the Treatment of Node-Positive Breast Cancer
$443,551Lori J Pierce · University Of Michigan At Ann Arbor · R01 · FY2006 · CA
Computer-aided tool for diagnostic breast ultrasound
$443,533Michael Galperin · Almen Laboratories, Inc. · R44 · FY2008 · CA
Scott and White Community Clinical Oncology Program
$443,531Scott And White Memorial Hospital · U10 · FY2004 · CA
Targeting Small Nucleolar RNA Augments Immunotherapeutic Efficacy
$443,515Chunru Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Mechano sensitive peptide aggregates for targeted therapy
$443,477Mathumai Kanapathipillai · University Of Michigan At Dearborn · R15 · FY2020 · GM
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model
$443,445David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Development of Mechanism-Based Strategies for the Treatment of Advanced Breast Ca
$443,410Neal Rosen · Sloan-Kettering Inst Can Research · P01 · FY2012 · CA